A detailed history of Silverarc Capital Management, LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 3,079,739 shares of EVGN stock, worth $7.05 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
3,079,739
Previous 3,085,503 0.19%
Holding current value
$7.05 Million
Previous $2.31 Million 13.53%
% of portfolio
0.57%
Previous 0.78%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.61 - $0.82 $3,516 - $4,726
-5,764 Reduced 0.19%
3,079,739 $2 Million
Q1 2024

May 14, 2024

SELL
$0.7 - $0.98 $10,147 - $14,207
-14,497 Reduced 0.47%
3,085,503 $2.31 Million
Q3 2023

Nov 13, 2023

BUY
$0.58 - $1.41 $1.74 Million - $4.23 Million
3,000,000 Added 3000.0%
3,100,000 $1.83 Million
Q2 2023

Aug 14, 2023

BUY
$0.56 - $1.2 $56,000 - $120,000
100,000 New
100,000 $107,000
Q4 2022

Feb 14, 2023

SELL
$0.61 - $8.13 $10,460 - $139,421
-17,149 Reduced 10.24%
150,361 $105,000
Q3 2022

Oct 28, 2022

SELL
$0.73 - $8.65 $25,412 - $301,123
-34,812 Reduced 17.21%
167,510 $139,000
Q2 2022

Jul 25, 2022

SELL
$0.75 - $1.33 $70,068 - $124,253
-93,424 Reduced 31.59%
202,322 $156,000
Q1 2022

May 13, 2022

BUY
$1.09 - $1.83 $2,931 - $4,920
2,689 Added 0.92%
295,746 $384,000
Q4 2021

Feb 14, 2022

BUY
$1.63 - $2.83 $72,909 - $126,585
44,730 Added 18.01%
293,057 $481,000
Q3 2021

Nov 15, 2021

SELL
$2.45 - $3.45 $276,671 - $389,598
-112,927 Reduced 31.26%
248,327 $656,000
Q2 2021

Aug 16, 2021

BUY
$3.3 - $5.02 $37,138 - $56,495
11,254 Added 3.22%
361,254 $1.24 Million
Q1 2021

May 18, 2021

SELL
$4.29 - $9.94 $1.07 Million - $2.49 Million
-250,000 Reduced 41.67%
350,000 $1.76 Million
Q4 2020

Feb 16, 2021

BUY
$2.41 - $5.63 $1.45 Million - $3.38 Million
600,000 New
600,000 $2.82 Million

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $94.4M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.